by editor | Aug 7, 2014 | Clinicians, Participants, Researchers
Lack of data underscores importance of ASPREE trial A large scientific review revealed that aspirin protected people aged 50-65 against gastrointestinal cancer, but was unable to determine cancer benefits for those aged over 70. International researchers, who analysed...
by editor | Aug 1, 2014 | Clinicians, Participants
An update on study updates We’ve had a fantastic time meeting participants and guests at study updates this year and are pleased to shared a few photos from some of the events. ASPREE Executive Officer, Associate Professor Robyn Woods, gave all the...
by editor | May 30, 2014 | Participants
High quality data answers important questions Principal Investigator to the Australian arm of the ASPREE trial, Professor John McNeil says health authorities require a high level of evidence about the balance of benefits and risks of aspirin in healthy people...
by editor | May 16, 2014 | Clinicians, Participants
Together we’ve reached a number of very important recruitment milestones! 1) ASPREE participants in the USA and Australia = 16,500 2) ASPREE participants in Australia = 14,500 3) ASPREE participants in Victoria = 10,500 4) ASPREE participants in Tasmania =...
by editor | Apr 17, 2014 | Participants
ASPREE jumped on board Yarra Trams’ Good Friday Appeal, resulting in two trams sporting the ASPREE logo in and around Melbourne. The Good Friday Appeal is a major Easter fundraiser for Victoria’s Royal Children’s Hospital. Above: ASPREE supports the Royal...
Recent Comments